Table 6. Robust RFs among five reconstructions under standard and low dose groups.
| ROI | Location | Standard-dose group | Low-dose group | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Overall (n=837) | First-order (n=18) | Texture (n=75) | Wavelet (n=744) | Overall (n=837) | First-order (n=18) | Texture (n=75) | Wavelet (n=744) | |||
| 1 | Right liver Lobe | 69 | 7 | 4 | 58 | 50 | 6 | 1 | 43 | |
| 2 | Left liver lobe | 73 | 7 | 5 | 61 | 56 | 7 | 2 | 47 | |
| 3 | Pancreas | 99 | 7 | 11 | 81 | 52 | 6 | 1 | 45 | |
| 4 | Spleen | 68 | 7 | 4 | 57 | 51 | 6 | 1 | 44 | |
| 5 | Right kidney | 88 | 9 | 7 | 72 | 70 | 8 | 3 | 59 | |
| 6 | Left kidney | 88 | 9 | 4 | 75 | 70 | 8 | 4 | 58 | |
| 7 | Right adrenal | 199 | 9 | 27 | 163 | 108 | 4 | 4 | 99 | |
| 8 | Left adrenal | 188 | 9 | 22 | 157 | 106 | 7 | 7 | 92 | |
| 9 | Aortaventralis | 72 | 7 | 5 | 60 | 59 | 7 | 3 | 49 | |
| 10 | Portal | 97 | 8 | 12 | 77 | 63 | 7 | 2 | 54 | |
| 11 | Postcava | 114 | 9 | 15 | 90 | 73 | 7 | 5 | 61 | |
| 12 | Visceral fat | 103 | 9 | 10 | 84 | 73 | 6 | 3 | 64 | |
| 13 | Subcutaneous fat | 126 | 8 | 15 | 103 | 85 | 7 | 7 | 72 | |
| 14 | Thoracic vertebrae | 89 | 11 | 10 | 68 | 82 | 9 | 5 | 68 | |
| 15 | Right erector spinae | 74 | 6 | 5 | 63 | 60 | 3 | 4 | 53 | |
| 16 | Left erector spinae | 84 | 6 | 7 | 71 | 59 | 3 | 5 | 51 | |
| 17 | Full-layer | 150 | 15 | 24 | 111 | 186 | 14 | 18 | 154 | |
| 18 | Hepatic mass | 328 | 18 | 50 | 260 | 243 | 8 | 30 | 205 | |
| 1–18 | Average | 117 | 9 | 13 | 95 | 86 | 7 | 6 | 73 | |
| Overall | 39 | 6 | 1 | 32 | 25 | 2 | 1 | 22 | ||
Data are presented as numbers. RFs, radiomics features; ROI, region of interest.